Anna Durbin

Professor, Department of International Health · Johns Hopkins Bloomberg School of Public Health

Credentials: · ·

History

Mechanisms of Protection and Durability for a Live Attenuated Tetravalent Dengue Vaccine
National Institute of Allergy and Infectious Diseases · U01
PI · $2M · University of Vermont & St Agric College
2019–2029
The Johns Hopkins Center for AIDS Research (JHU CFAR)
National Institute of Allergy and Infectious Diseases · P30
Project lead · $488K · Johns Hopkins University
2012–2027
Task A31: Fungal In Vitro Screening
NIH Office of the Director · N01
Contact PI · $4.6M · University of Texas Hlth Science Center
2023–2026

Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2024–2025
Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2022–2024
An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge
Principal investigator · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2022–2024
Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2018–2022